Clinical Trial Update: Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

The document reports completion of a Phase 1/Phase 2a study evaluating Nimotuzumab for colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED